AQR Capital Management
DCPH

AQR Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

AQR Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-45,036
Closed -$708K – 2702
2024
Q1 		$708K Sell
45,036
-14,034
-24% -$216K ﹤0.01% 1823
2023
Q4 		$953K Buy
59,070
+3,422
+6% +$43.7K ﹤0.01% 1619
2023
Q3 		$708K Sell
55,648
-8,373
-13% -$116K ﹤0.01% 1726
2023
Q2 		$901K Buy
64,021
+32,671
+104% +$467K ﹤0.01% 1598
2023
Q1 		$484K Buy
+31,350
New +$523K ﹤0.01% 1790
2021
Q1 		– Sell
-7,019
Closed -$401K – 2284
2020
Q4 		$401K Sell
7,019
-16,740
-70% -$992K ﹤0.01% 1863
2020
Q3 		$1.22M Buy
23,759
+4,016
+20% +$197K ﹤0.01% 1319
2020
Q2 		$1.18M Sell
19,743
-5,468
-22% -$292K ﹤0.01% 1392
2020
Q1 		$1.04M Buy
25,211
+6,198
+33% +$344K ﹤0.01% 1332
2019
Q4 		$1.18M Buy
+19,013
New +$904K ﹤0.01% 1457
2019
Q1 		– Sell
-10,312
Closed -$216K – 2236
2018
Q4 		$216K Buy
+10,312
New +$254K ﹤0.01% 2055

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

AQR Capital Management's DCPH Position: Q2 2024 in Review

AQR Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 45,036 shares — an estimated $708K sold.

AQR Capital Management first reported a position in DCPH in Q4 2018 and held it in 11 quarters. The position peaked at $1.22M in Q3 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • AQR Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • AQR Capital Management sold 45,036 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $708K.
  • AQR Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 11 quarters.
  • AQR Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.22M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.